Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05
Clinical trial NCT01725269 · TERMINATED
Trial details
- NCT number
- NCT01725269
- Sponsor
- Aires Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-04-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.